Appropriate Conditions for the Higf Gene Transfecting the Cultured Meniscial Fibrochondrocytes

张海宁,侯筱魁,汤亭亭,张洁,冷萍

DOI: https://doi.org/10.3969/j.issn.1005-8478.2004.23.030

2004-01-01

Abstract:Objective: To explore the appropriate transfect conditions for cationic liposome FuGene 6 mediate recombinant plasmid pIRES_2-EGFP-hIGF to transfect the cultured meniscal fibrochandrocytes.Method: The meniscus were granulated, and digested with type II collagenase.Fibrochondrocytes were collected and cultured at condition of 37℃, 5%CO_2 and saturated humidity.Growing curve and trypan blue stain were applied either to determine the vitality of the cells.Then the recombinant plasmid was transfected into cells by FuGene 6 with different percentages.After transfection, the EGFP was observed with the reverse fluorescent microscope at different time points.Transfect efficiency was also detected based on whether the cells were pretreated by hyaluronidase.The mixture of FuGene 6 and plasmid was added into the culture medium or onto the cells directly without the culture medium.The fibrochondrocytes were selected by G418 to determine which concentration of the antibiotics was the appropriate one.Result: Meniscal fibrochondrocytes adhered to the disk and elongated into long shuttle-like or polygonal shapes.The expression of EGFP was first found at 4 hours after transfection and increased gradually.The highest efficiency can be achieved by proportion of 3∶1, and the consequence was 6∶1, whereas the lowest were 2∶1 and 3∶2.Fibrochondrocytes pretreated by hyaluronidase expressed more EGFP than the control group.No distinct difference was observed between groups of adding the mixture into the culture medium or onto the cells directly.The appropriate concentration for G418 selection was 400 mg/L.Conclusion: The hIGF-I gene can be transfected efficiently and safely into the cultured meniscal fibrochondrocytes by liposome reagent FuGene 6.Higher efficiency can be achieved by transfecting the cells with the 3∶1 proportion and pretreating the cells with hyaluronidase before the transfection procedure.